1de Vos M, Verdievel H, Schoonjans R, et al. Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparation[J]. Gut, 1992,33( 10):1338.
2Frieri G, Pimpo MT,Palumbo G, et al. Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn' s disease: a GISC study [ J ]. Am J Gastroenterol, 2000, 95(6): 1486.
3Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation[ J]. Int J Pharm, 2002,235(1-2):1.
4Prasad YV, Krishnaiah YS, Satyanarayana S. In vitro evaluation of guargumasa carrier for colon soecific drug delivery [ J ]. J Controlled Release, 1998,51(2-3) :281.
5Khan AKA, Piris J, Truelone Sc. An experiment to determine the active therapeutic moiety of sulphasalazine [ J ]. Lancet, 1977,2 (8804):892.
6Tozaki H, Nishioka J, Komoike J, et al. Enhanced absorption of insulin and [ Asu (1,7) ] eel-calcitonin using novel azopolymer coated pellets for colon-specific drug delivery[ J]. J Pharm Sci,2001,90( 1 ):89.
7Tozaki H, Komoike J, Tada C, et al. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon[J]. J Pharm Sci, 1997,86(9): 1016.
8Rama-Prasad YV, Krishnaiah YS, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery [ J ] . J Controlled Release, 1998,51 ( 2-3 ) :281.
9Chiu HC, Hsiue GH, Lee YP, et al. Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system[J]. J Biomater Sci Polym Ed, 1999,10(5) :591.
10Sinba VR, Kumria R. Polysaccharides in colon specific drug delivery[J]. Int J Pharm,2001,224(1-2) : 19.
